NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Nasdaq Rises Over 200 Points; Apple Posts Upbeat Earnings

Published 02/02/2024, 17:08
Updated 02/02/2024, 18:10
© Reuters.  Nasdaq Rises Over 200 Points; Apple Posts Upbeat Earnings
AAPL
-
IXIC
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Friday.

The Dow traded up 0.19% to 38,593.49 while the NASDAQ rose 1.55% to 15,600.39. The S&P 500 also rose, gaining, 0.97% to 4,953.70.

Check This Out: Amazon To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday

Leading and Lagging Sectors

Communication services shares rose by 4.1% on Friday.

In trading on Friday, real estate shares fell by 2.3%.

Top Headline

Apple Inc. (NASDAQ: AAPL) reported better-than-expected earnings and revenue for its first quarter.

The iPhone maker reported first-quarter earnings per share of $2.18 and revenue of $119.6 billion, thanks to record Services revenue and iPhone revenue. However, the company reported a revenue decline in China.

Equities Trading UP

Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares shot up 80% to $4.34.

Intelligent Bio Solutions said it sees preliminary second-quarter revenue of $0.76 million.

Shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) got a boost, surging 23% to $15.99. Tyra Biosciences announced a $200 million private placement financing.

Meta Platforms, Inc. (NASDAQ: META) shares were also up, gaining 21% to $478.68 as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents per share.

Equities Trading DOWN

Cingulate Inc. (NASDAQ: CING) shares dropped 49% to $1.72. Cingulate announced pricing of $7.5 million public offering of 3.750 million shares at $2.00 per share.

Shares of Gen Digital Inc. (NASDAQ: GEN) were down 19% to $19.35 after the company reported worse-than-expected third-quarter financial results and issued FY24 adjusted EPS and FY24 revenue guidance below estimates.

GRI Bio, Inc. (NASDAQ: GRI) was down, falling 25% to $1.4501 after the company announced pricing of $5.5 million public offering.

Also Check This Out: Top 4 Health Care Stocks That May Crash This Quarter

Commodities

In commodity news, oil traded down 1.8% to $72.48 while gold traded down 1% at $2,050.70.

Silver traded down 2.2% to $22.73 on Friday while copper fell 0.5% to $3.8345.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 gained 0.17%, London’s FTSE 100 rose 0.08% while Spain’s IBEX 35 Index rose 0.57% The German DAX rose 0.34% French CAC 40 rose 0.18% while Italy’s FTSE MIB Index rose 0.21%.

Industrial production in France rose 1.1% month-over-month in December following a 0.5% increase in the prior period. The number of foreign tourist arrivals in Spain surged by 26.2% year-over-year to 5.2 million in December.

Asia Pacific Markets

Asian markets closed mixed on Friday, with Japan’s Nikkei 225 gaining 0.41%, Hong Kong’s Hang Seng Index falling 0.21% and China’s Shanghai Composite Index falling 1.46%. India’s S&P BSE Sensex, meanwhile, rose 0.61%.

Australian final demand producer price index rose by 0.9% quarter-over-quarter in the fourth quarter, versus a 1.8% rise in the third quarter.

Economics

Non-farm payrolls increased by 353,000 in January, a jump from the upwardly revised figure of 333,000 for December and well above the expected 180,000.

The unemployment rate remained steady at 3.7%, below the expected 3.8%.

Average hourly earnings showed 0.6% growth for the month, a sharp increase from the previous 0.4% and below the predicted 0.3%.

New orders for US manufactured goods rose 0.2% month-over-month in December versus a 2.6% increase in November.

The University of Michigan consumer sentiment rose to 79 in January versus a preliminary level of 78.9.

Now Read This: DoorDash, KB Home And 2 Other Stocks Insiders Are Selling

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.